Form4insider filings, from the source

SEC Form 4 · accession 0001140361-15-010609

BIOMARIN PHARMACEUTICAL INC · BMRN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jean Jacques Bienaime
Officer — Chief Executive Officer · Director
Period of report
Mar 3, 2015
Accepted (ET)
Mar 5, 2015 · 8:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Mar 3, 2015A39,600$0.00A254,757D
Common StockF2Mar 5, 2015M10,000$12.99A52,279IShares held by Bienaime Family Trust
Common StockF3,F2Mar 5, 2015S10,000$113.7016D42,279IShares held by Bienaime Family Trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy) Common StockF4$108.36Mar 3, 2015A90,500ASep 3, 2015Mar 2, 2025Common Stock90,50090,500D
Stock Option (right to buy Common Stock)F5$12.99Mar 5, 2015M10,000DNov 11, 2006May 10, 2016Common Stock10,00051,500I
Stock Option (right to buy Common Stock)F6,F5$12.99holding———Nov 11, 2006May 10, 2016Common Stock10,00010,000I
Stock Option (right to buy Common Stock)F6,F5$12.99holding———Nov 11, 2006May 10, 2016Common Stock10,00010,000I
Stock Option (right to buy Common Stock)F6,F5$12.99holding———Nov 11, 2006May 10, 2016Common Stock10,00010,000I
Stock Option (right to buy Common Stock)F6,F5$12.99holding———Nov 11, 2006May 10, 2016Common Stock10,00010,000I
Stock Option (right to buy Common Stock)F6,F5$12.99holding———Nov 11, 2006May 10, 2016Common Stock20,00020,000I

Explanation of responses